HAE
HAEMONETICS CORP
NYSE · Healthcare · Medical - Instruments & Supplies · US
$108.42
+0.76%Sep 15, 2026, 12:30 UTC
Haemonetics Corporation acquired Vivasure Medical Limited, with Orchestra BioMed receiving a $6.1 million milestone payment on September 14, 2026 as part of the deal.
Source:Aug 18, 2026, 23:49 UTC
Haemonetics Corp shares surged 15.9% to $104.65 on August 18, 2026.
Source:Aug 6, 2026, 10:00 UTC
Haemonetics Corporation announced that its financial results for the first quarter of fiscal year 2027, which ended June 27, 2026, are available on its Investor Relations website.